Godavari Drugs Limited

BSE: 530317
Godavari Drugs Limited - chemicals and materials in Secunderabad, Telangana, India. FY 2026 financials and compliance.
CIN L24230TG1987PLC008016 Incorporated 02 December 1987 ROC Hyderabad HQ Secunderabad, Telangana, India
Active Listed - BSE: 530317 Public Limited Company chemicals and materials
Data last updated
Revenue · FY 2026
₹105.81 Cr
▼ 6.65% YoY
Computed EBITDA · FY 2026
₹11.12 Cr
▼ 13.16% YoY
Net profit · FY 2026
₹4.09 Cr
▼ 6.64% YoY
Authorised capital
₹20 Cr
Registered with MCA
Paid-up capital
₹10.13 Cr
Issued & subscribed
Open charges
₹91.64 Cr
Satisfied ₹110.23 Cr
Company age
39 yrs
Est. 1987
Employees · EPFO
92
Latest available

About Godavari Drugs Limited

Data last updated: 14 July 2026

Godavari Drugs Limited is a public limited company based in Secunderabad, Telangana, India. It specialises in specialty chemicals, a part of the broader chemicals and materials sector. Incorporated on 02 December 1987, the company has been in operation for over 39 years.

Registered with ROC Hyderabad under CIN L24230AP1987PTC008016. Listed on BSE: 530317.

Capital: an authorised share capital of ₹20 Cr and a paid-up capital of ₹10.13 Cr. Formerly known as Godavari Drugs Private Limited. It is led by directors including Mohit Jaju and Mukund Kakani.

Last AGM: 27 September 2025. Financial statements filed for year ended 31 March 2025. Office: 1 – 8 – 303/34 S.P. Road Secunderabad. Secunderabad, Telangana, India – 500003.

As per BSE-filed standalone financials for FY 2026, the company reported a revenue of ₹105.81 Cr, a decline of 6.65% compared to the previous year. The net worth stands at ₹75.8 Cr (up 74.87% YoY). Total assets are valued at ₹200.43 Cr (up 40.09% YoY).

The company has a workforce of approximately 92 employees as per the latest available data.

The company is associated with 1 brand - Godavaridrugs. As per MCA filings, the company has open charges of ₹91.64 Cr and satisfied charges of ₹110.23 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website godavaridrugs.com.

Company Details of Godavari Drugs Limited
CIN L24230TG1987PLC008016
Registration Number 008016
Incorporation Date 02 December 1987
ROC Hyderabad
Listing Status Listed (BSE: 530317)
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Mukund Kakani Managing Director Mohit Jaju Whole-Time Director Ghanshyam Jaju Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    1 – 8 – 303/34 S.P. Road Secunderabad. Secunderabad, Telangana, India – 500003
  • Industry
    Chemicals and Materials, Specialty Chemicals
Company report
Godavari Drugs Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Godavari Drugs Limited report

Financials, compliance, directors, charges, ownership and filings for Godavari Drugs Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Godavari Drugs Limited

Godavari Drugs Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24230TG1987PLC008016, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L24230TG1987PLC008016 Current
L24230AP1987PTC008016 Previous
L24230AP1987PLC008016 Previous

Associated Brands with Godavari Drugs Limited

Godavari Drugs Limited operates one associated brand: Godavaridrugs. These brands represent Godavari Drugs Limited's diversified market presence and brand portfolio.

Brand Description Website
Godavaridrugs
CMO services for APIs, intermediates, and fine chemicals are offered. godavaridrugs.com

Competitors & Alternatives of Godavari Drugs Limited

Brands and companies operating in the same space as Godavari Drugs Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.

Competitor Description Location Founded
Laurus Labs Laurus Labs Pharmaceutical and biotechnology company Hyderabad, India, India 2005
Symbiotec Symbiotec Non-sterile steroid hormone-based APIs and intermediates are manufactured. Indore, India, India 2002
Beijing Biostar Technologies Beijing Biostar Technologies APIs, intermediates, and biochemical reagents are developed and manufactured. Beijing, China, China 2002
Sterling Pharma Solutions Sterling Pharma Solutions Contract development, manufacturing, and analytical services for APIs are offered. Dudley, United Kingdom, United Kingdom 2016
Provepharm Life Solutions Provepharm Life Solutions APIs and drug products are developed and valorized in pharmaceuticals. Marseille, France, France 1998
Hikal Hikal APIs and intermediates are produced via custom synthesis and research. Mumbai, India, India 1988
Snapdragon Chemistry Snapdragon Chemistry Drug discovery and development service provider Cambridge, United States, United States 2014
SeQuent SeQuent APIs are developed and manufactured for therapeutic areas. Bengaluru, India, India 2002
Jubilant Pharma Jubilant Pharma Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. Noida, India, India 1978

Business Activity of Godavari Drugs Limited

Godavari Drugs Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Godavari Drugs Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Godavari Drugs Limited

Godavari Drugs Limited is audited by Ayyadevara & Co (ICAI peer reviewed, certificate valid till 2028-10-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
Ayyadevara & Co (ICAI peer reviewed, certificate valid till 2028-10-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Godavari Drugs Limited

Godavari Drugs Limited is currently managed by 6 directors, with 9 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Mohit Jaju Whole-Time Director 10 May 2012 14 Years 2 Months Current
Mukund Kakani
Also directs: Godavari Capital Private Limited
Managing Director 03 Dec 1987 38 Years 7 Months Current
Ghanshyam Jaju
Also directs: Sumarg Warehouse Llp, Godavari Capital Private Limited, Godavari Homes Ltd
Director 03 Dec 1987 38 Years 7 Months Current
Mahendra Uday Bhalerao
Also directs: Nichino India Private Limited
Director 12 Nov 2022 3 Years 8 Months Current
Shilpa Bung
Also directs: Naughty Rabbit Llp, Sigachi Laboratories Limited, Viaton Energy Private Limited and 1 more
Director 29 May 2025 1 Years 1 Months Current
Dinesh Udpa
Also directs: Neuton Auto Private Limited
Director 13 Feb 2024 2 Years 5 Months Current
View all directors

Financials of Godavari Drugs Limited FY 2026 filings available

Godavari Drugs Limited reported revenue of ₹105.81 Cr (down 6.65% YoY) for FY 2026.

Revenue · FY 2026
₹105.81 Cr ▼ 6.65%
Profit · FY 2026
₹4.09 Cr ▼ 6.64%
Computed EBITDA · FY 2026
₹11.12 Cr ▼ 13.16%
Revenue₹ Cr · Standalone0100200FY 2019: ₹84 Cr83.5FY 2019FY 2020: ₹96 Cr · +14.5% YoY95.7+14.5%FY 2020FY 2021: ₹123 Cr · +28.2% YoY123+28.2%FY 2021FY 2022: ₹161 Cr · +31.3% YoY161+31.3%FY 2022FY 2023: ₹160 Cr · -0.9% YoY160-0.9%FY 2023FY 2024: ₹157 Cr · -1.8% YoY157-1.8%FY 2024FY 2025: ₹113 Cr · -27.7% YoY113-27.7%FY 2025FY 2026: ₹106 Cr · -6.7% YoY106-6.7%FY 2026
Net Profit₹ Cr · Standalone0246FY 2019: ₹1 Cr1.2FY 2019FY 2020: ₹2 Cr · +65.6% YoY2+65.6%FY 2020FY 2021: ₹4 Cr · +106.3% YoY4.1+106.3%FY 2021FY 2022: ₹5 Cr · +27.1% YoY5.2+27.1%FY 2022FY 2023: ₹4 Cr · -27.8% YoY3.8-27.8%FY 2023FY 2024: ₹6 Cr · +46.6% YoY5.5+46.6%FY 2024FY 2025: ₹4 Cr · -21.1% YoY4.4-21.1%FY 2025FY 2026: ₹4 Cr · -6.6% YoY4.1-6.6%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year02040Q1'25: ₹32 Cr32.2Q1'25Q2'25: ₹26 Cr26.1Q2'25Q3'25: ₹30 Cr29.6Q3'25Q4'25: ₹26 Cr25.5Q4'25Q1'26: ₹24 Cr · -26.1% YoY23.8-26.1%Q1'26Q2'26: ₹27 Cr · +2.2% YoY26.6+2.2%Q2'26Q3'26: ₹22 Cr · -24.9% YoY22.2-24.9%Q3'26Q4'26: ₹33 Cr · +30% YoY33.2+30%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹105.81 Cr ₹113.35 Cr ₹156.71 Cr ₹159.62 Cr ₹161.11 Cr ₹122.67 Cr ₹95.7 Cr ₹83.54 Cr
Other Income ₹80.51 Lakh ₹97.72 Lakh ₹61.75 Lakh ₹65.53 Lakh ₹27.63 Lakh ₹41.01 Lakh ₹32.77 Lakh ₹24.47 Lakh
Total Income ₹106.61 Cr ₹114.33 Cr ₹157.33 Cr ₹160.28 Cr ₹161.38 Cr ₹123.08 Cr ₹96.03 Cr ₹83.79 Cr
Cost of Materials Consumed ₹88.89 Cr ₹85.24 Cr ₹121.95 Cr ₹137.82 Cr ₹127.97 Cr ₹94.15 Cr ₹77.38 Cr ₹66.95 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹11.39 Cr -₹3.58 Cr -₹1.14 Cr -₹9.76 Cr ₹2.48 Cr ₹2.44 Cr -₹71.11 Lakh -₹2.04 Cr
Employee Benefit Expense ₹5.7 Cr ₹5.03 Cr ₹5.13 Cr ₹4.84 Cr ₹4.96 Cr ₹3.94 Cr ₹3.45 Cr ₹3.45 Cr
Finance Costs ₹3.98 Cr ₹4.73 Cr ₹4.92 Cr ₹3.93 Cr ₹2.85 Cr ₹3.31 Cr ₹2.91 Cr ₹2.89 Cr
Depreciation & Amortisation ₹2.43 Cr ₹2.45 Cr ₹1.99 Cr ₹1.94 Cr ₹1.7 Cr ₹1.22 Cr ₹1.16 Cr ₹1.09 Cr
Other Expenses ₹12.3 Cr ₹14.84 Cr ₹17.47 Cr ₹16.81 Cr ₹14.4 Cr ₹12.31 Cr ₹9.55 Cr ₹9.7 Cr
Total Expenses ₹101.91 Cr ₹108.7 Cr ₹150.32 Cr ₹155.57 Cr ₹154.36 Cr ₹117.37 Cr ₹93.74 Cr ₹82.04 Cr
Profit Before Exceptional Items & Tax ₹4.71 Cr ₹5.63 Cr ₹7.01 Cr ₹4.71 Cr ₹7.02 Cr ₹5.71 Cr ₹2.29 Cr ₹1.75 Cr
Exceptional Items ₹35.51 Lakh ₹0 -₹9.04 Lakh ₹22.95 Lakh ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹5.06 Cr ₹5.63 Cr ₹6.92 Cr ₹4.93 Cr ₹7.02 Cr ₹5.71 Cr ₹2.29 Cr ₹1.75 Cr
Total Tax Expense ₹97.39 Lakh ₹1.25 Cr ₹1.37 Cr ₹1.15 Cr ₹1.78 Cr ₹1.58 Cr ₹28.82 Lakh ₹53.74 Lakh
Net Profit ₹4.09 Cr ₹4.38 Cr ₹5.55 Cr ₹3.79 Cr ₹5.25 Cr ₹4.13 Cr ₹2 Cr ₹1.21 Cr
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹4.09 Cr ₹4.38 Cr ₹5.55 Cr ₹3.79 Cr ₹5.25 Cr ₹4.13 Cr ₹2 Cr ₹1.21 Cr
EBITDA (computed) ₹11.12 Cr ₹12.81 Cr ₹13.92 Cr ₹10.58 Cr ₹11.57 Cr ₹10.24 Cr ₹6.36 Cr ₹5.72 Cr
Basic EPS ₹5.43 ₹5.82 ₹7.37 ₹5.03 ₹6.97 ₹5.48 ₹2.66 ₹1.60
Diluted EPS ₹5.36 ₹5.82 ₹7.37 ₹5.03 ₹6.97 ₹5.48 ₹2.66 ₹1.60
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹200.43 Cr ₹143.08 Cr ₹134.75 Cr ₹121.43 Cr ₹101.41 Cr ₹91.14 Cr ₹83.92 Cr ₹74.65 Cr
Non-current Assets ₹88.63 Cr ₹64.31 Cr ₹46.27 Cr ₹34.43 Cr ₹27.08 Cr ₹23.53 Cr ₹23.09 Cr ₹17.24 Cr
Current Assets ₹111.8 Cr ₹78.76 Cr ₹88.48 Cr ₹87 Cr ₹74.33 Cr ₹67.61 Cr ₹60.83 Cr ₹57.41 Cr
Property, Plant & Equipment ₹30.31 Cr ₹32.61 Cr ₹26.68 Cr ₹24.91 Cr ₹26.25 Cr ₹22.43 Cr ₹13.81 Cr ₹14.97 Cr
Inventories ₹46.06 Cr ₹27.94 Cr ₹20.65 Cr ₹19.86 Cr ₹10.03 Cr ₹14.65 Cr ₹17.75 Cr ₹16.47 Cr
Trade Receivables ₹43.58 Cr ₹42.32 Cr ₹59.42 Cr ₹57.93 Cr ₹55.58 Cr ₹45.12 Cr ₹36.02 Cr ₹33.96 Cr
Cash & Equivalents ₹14.51 Cr ₹2.37 Cr ₹2.62 Cr ₹3.08 Cr ₹2.28 Cr ₹1.64 Cr ₹1.43 Cr ₹1.53 Cr
Equity (Net Worth) ₹75.8 Cr ₹43.35 Cr ₹38.97 Cr ₹33.42 Cr ₹29.63 Cr ₹24.39 Cr ₹20.26 Cr ₹18.26 Cr
Equity Share Capital ₹10.13 Cr ₹7.53 Cr ₹7.53 Cr ₹7.53 Cr ₹7.53 Cr ₹7.53 Cr ₹7.53 Cr ₹7.53 Cr
Borrowings (Non-current) ₹36.97 Cr ₹23.9 Cr ₹11.17 Cr ₹11.95 Cr ₹11.78 Cr ₹14.49 Cr ₹11.16 Cr ₹8.01 Cr
Borrowings (Current) ₹39.39 Cr ₹37.73 Cr ₹44.46 Cr ₹21.55 Cr ₹8.56 Cr ₹13.59 Cr ₹14.91 Cr ₹13 Cr
Total Debt (computed) ₹76.36 Cr ₹61.63 Cr ₹55.62 Cr ₹33.5 Cr ₹20.34 Cr ₹28.08 Cr ₹26.08 Cr ₹21.01 Cr
Current Liabilities ₹85.14 Cr ₹73.09 Cr ₹82 Cr ₹73.71 Cr ₹57.76 Cr ₹50.51 Cr ₹51.25 Cr ₹46.22 Cr
Total Liabilities ₹124.63 Cr ₹99.73 Cr ₹95.79 Cr ₹88.02 Cr ₹71.78 Cr ₹66.75 Cr ₹63.66 Cr ₹56.39 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹73.35 Lakh ₹11.2 Cr ₹18.41 Cr ₹13.22 Cr ₹11.23 Cr
Investing Cash Flow -₹25.95 Cr -₹19.51 Cr -₹13.22 Cr -₹8.64 Cr -₹4.97 Cr
Financing Cash Flow ₹37.35 Cr ₹8.07 Cr -₹5.65 Cr -₹3.77 Cr -₹5.62 Cr
Capital Expenditure ₹26.72 Cr ₹20 Cr ₹13.2 Cr ₹9.3 Cr ₹5.25 Cr
Free Cash Flow (computed) -₹25.99 Cr -₹8.8 Cr ₹5.21 Cr ₹3.92 Cr ₹5.98 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash ₹12.14 Cr -₹24.96 Lakh -₹46.17 Lakh ₹80.83 Lakh ₹63.81 Lakh
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹33.16 Cr ₹22.18 Cr ₹26.65 Cr ₹23.81 Cr ₹25.5 Cr ₹29.55 Cr ₹26.09 Cr ₹32.21 Cr
Other Income ₹14.12 Lakh ₹1.63 Lakh ₹63.54 Lakh ₹1.22 Lakh ₹10.51 Lakh ₹9.76 Lakh ₹94,000 ₹76.51 Lakh
Total Income ₹33.3 Cr ₹22.2 Cr ₹27.28 Cr ₹23.82 Cr ₹25.61 Cr ₹29.65 Cr ₹26.1 Cr ₹32.97 Cr
Cost of Materials Consumed ₹30.27 Cr ₹16.64 Cr ₹23.99 Cr ₹17.99 Cr ₹21.73 Cr ₹19.59 Cr ₹16.98 Cr ₹26.95 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹4.9 Cr -₹1.76 Cr -₹3.88 Cr -₹85.41 Lakh -₹4.13 Cr ₹3.5 Cr ₹59.25 Lakh -₹3.54 Cr
Employee Benefit Expense ₹1.32 Cr ₹1.58 Cr ₹1.44 Cr ₹1.36 Cr ₹1.4 Cr ₹98.35 Lakh ₹1.38 Cr ₹1.26 Cr
Finance Costs ₹95.55 Lakh ₹1.11 Cr ₹90.84 Lakh ₹1 Cr ₹1.11 Cr ₹1.11 Cr ₹1.08 Cr ₹1.44 Cr
Depreciation & Amortisation ₹61.21 Lakh ₹61.2 Lakh ₹60.37 Lakh ₹60.43 Lakh ₹67.15 Lakh ₹64.43 Lakh ₹58.22 Lakh ₹54.96 Lakh
Other Expenses ₹3.53 Cr ₹3.25 Cr ₹3.1 Cr ₹2.42 Cr ₹3.39 Cr ₹2.9 Cr ₹4.24 Cr ₹4.3 Cr
Total Expenses ₹31.79 Cr ₹21.43 Cr ₹26.16 Cr ₹22.52 Cr ₹24.17 Cr ₹28.73 Cr ₹24.85 Cr ₹30.96 Cr
Profit Before Exceptional Items & Tax ₹1.51 Cr ₹77.05 Lakh ₹1.12 Cr ₹1.3 Cr ₹1.44 Cr ₹92.13 Lakh ₹1.25 Cr ₹2.01 Cr
Exceptional Items ₹10.38 Lakh ₹25.13 Lakh ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹1.62 Cr ₹1.02 Cr ₹1.12 Cr ₹1.3 Cr ₹1.44 Cr ₹92.13 Lakh ₹1.25 Cr ₹2.01 Cr
Total Tax Expense ₹32.68 Lakh ₹26.42 Lakh ₹12.06 Lakh ₹26.17 Lakh ₹54.67 Lakh ₹15.39 Lakh ₹16.35 Lakh ₹38.13 Lakh
Net Profit ₹1.29 Cr ₹75.76 Lakh ₹1 Cr ₹1.04 Cr ₹89.31 Lakh ₹76.74 Lakh ₹1.09 Cr ₹1.63 Cr
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹1.29 Cr ₹75.76 Lakh ₹1 Cr ₹1.04 Cr ₹89.31 Lakh ₹76.74 Lakh ₹1.09 Cr ₹1.63 Cr
EBITDA (computed) ₹3.08 Cr ₹2.49 Cr ₹2.63 Cr ₹2.91 Cr ₹3.22 Cr ₹2.68 Cr ₹2.91 Cr ₹4 Cr
Basic EPS ₹1.71 ₹1.01 ₹1.33 ₹1.38 ₹1.19 ₹1.02 ₹1.45 ₹2.17
Diluted EPS ₹1.64 ₹1.01 ₹1.33 ₹1.38 ₹1.19 ₹1.02 ₹1.45 ₹2.17
Latest 8 quarters shown.
Segment · FY 2021 (annual) Revenue Result (PBIT) Assets Liabilities
Segment Revenue (Income) ₹0 ₹0 - -
Want more history and ratios?
You're viewing the latest exchange-filed financials for Godavari Drugs Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Charges & Borrowings of Godavari Drugs Limited

Open charges
₹91.64 Cr
Satisfied charges
₹110.23 Cr
Breakdown by lending institutions
Yes Bank Limited₹48.24 Cr
Others₹43.40 Cr
Latest charge details
DateLenderAmountStatus
18 Feb 2025 Others ₹43.4 Cr Open
05 Jul 2018 Yes Bank Limited ₹48.24 Cr Open
31 May 2022 The Hongkong and Shanghai Banking Corporation Limited ₹2.9 Cr Satisfied
30 Mar 2022 The Hongkong and Shanghai Banking Corporation Limited ₹43.4 Cr Satisfied
10 Apr 2017 Others ₹3.7 Cr Satisfied

Total charge records: 23 View all charges

Employees and EPFO Compliance at Godavari Drugs Limited

View historical data on people associated with Godavari Drugs Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Godavari Drugs Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Godavari Drugs Limited

Premium access

GST registrations and filing compliance for Godavari Drugs Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Godavari Drugs Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Godavari Drugs Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Godavari Drugs Limited

Premium access

MSME payment history for Godavari Drugs Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Godavari Drugs Limited

Premium access

Corporate group structure for Godavari Drugs Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Godavari Drugs Limited

Premium access

MCA filings and documents for Godavari Drugs Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Godavari Drugs Limited

Activity
27 Sep 2025
Godavari Drugs Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Directors
29 May 2025
Shilpa Bung was appointed as a Director on 29 May 2025 & has been associated with this company since 1 year 1 month.
Charges
22 May 2025
A charge with Others of Rs. 43.40 Cr registered on 18 Feb 2025 with Charge ID 101048560 was modified on 22 May 2025.
Charges
15 Apr 2025
A charge registered on 31 May 2022 via Charge ID 100579862 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 15 Apr 2025.
Charges
15 Apr 2025
A charge registered on 30 Mar 2022 via Charge ID 100563735 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 15 Apr 2025.
Activity
31 Mar 2025
Godavari Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.

Recent News on Godavari Drugs Limited

India's Godavari Drugs Dec-Qtr Profit Falls
13 Feb 2018 · Financetime

Frequently Asked Questions about Godavari Drugs Limited

Godavari Drugs Limited is an active public limited company in the chemicals and materials sector based in Secunderabad, Telangana, India. It was incorporated on 02 December 1987 (39+ years old) and is registered under CIN L24230TG1987PLC008016. Listed on BSE: 530317. The company has 92 employees.

Godavari Drugs Limited reported revenue of ₹105.81 Cr for FY 2026 (down 6.65% YoY) based on standalone BSE filings.

The current directors of Godavari Drugs Limited are:

The primary industry of Godavari Drugs Limited is chemicals and materials. The company specifically operates in specialty chemicals. The company is currently active in this sector.

Yes. Godavari Drugs Limited is listed on BSE with code 530317.

Godavari Drugs Limited can be reached at the registered office: 1 – 8 – 30334 S.P. Road Secunderabad. Secunderabad, Telangana, India – 500003, or through the website godavaridrugs.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available